Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy in High Grade MPNST
NCT00304083Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Dec 2005
- Primary completion
- Jun 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin, ifosfamide, etoposide in malignant peripheral nerve sheath tumor (MPNST), sponsored by Sarcoma Alliance for Research through Collaboration. Started Dec 2005; status: completed.
02
Drugs
pegylated liposomal doxorubicinifosfamideetoposide
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT00304083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304083.